Anaxomics has developed several technological innovations, including their proprietary Therapeutic Performance Mapping System (TPMS) and Drug-to-Target and Target Profiling Technologies. Currently, they are able to perform high-quality services which accelerate discovery, improve the quality of research and reduce costs.
|
press_release_anaxomics.pdf | |
File Size: | 168 kb |
File Type: |
Vanessa’s personal journey with her sister, combined with the community needs, have been the impetus to focus the APCDG activities.
Vanessa received a bachelor’s degree in Biological Sciences from Badajoz University (Spain). She holds a PhD (Sc.D.) in Cell and Developmental Biology from the Center for Genomic Regulation, University of Pompeu Fabra, Biomedical Research Park in Barcelona (PRBB). In 2014, she completed her background with an International MBA from IAE de Paris, Sorbonne Graduate Business School. |
Our work is publicly available to help the CDG community and related rare disease communities. Importantly, we do not receive government funding. We rely solely on donations in order to continue our projects. Consider to make a donation using Paypal, debit or credit card or bank transfer. |